Physical fitness reduces the risk of colon cancer in people with family adenomatous polyposis

Physical fitness reduces the risk of colon cancer in people with family adenomatous polyposis
reference
t. Nakamura, H. Ishikawa, T. Sakai et al. Influence of physical fitness on colorectal tumor development in patients with family adenomatous polyposis. Medicine (Baltimore) . 2019; 98 (38): E17076.
Study goal
The authors assessed the influence of physical fitness, measured by stress tests, the risk of developing colon cancer (CRC) in people with family adenomatous polyposis (FAP).
draft
This is a double-blind cross-sectional study with patients who had previously participated in 2 CRC prevention studies (J-Fapp study and J-Fapp study II) who were both double-blind, randomized multicenter studies.
participant
A total of 119 people (54 men and 65 women) aged 17 to 73 took part in the study. 43 of the participants had a CRC history, the other 76 not.
either clinical symptoms or a parent who had FAP caused the diagnosis of FAP. In the study, 116 of the 119 participants were subjected to a genetic test, and 98 of these people were positively tested for a pathological mutation in their germination line apc gen. No significant differences in relation to the history of CRC were found.
Physical movement to reduce the risk of sporadic and genetically induced CRC is an effective treatment that goes beyond its effectiveness.
Since FAP is an inherited illness, the study included 10 cases in which 2 members of the same family took part, and 7 cases in which 3 members of the same family took part. The researchers carried out preliminary analyzes according to family lines, but found no observable differences in the results.
study parameters evaluated
All participants were subjected twice between September 2000 and August 2007, first at the time of the setting, followed by another test 2 years later. The participants led the stress test in the form of a postprandial level test at least 2 hours after the last meal and after confirming lactic acid levels (LA) in the blood in the rest of the state by < 1.5 mmol/l. The heart rate (HR) was measured immediately after the step test and the predicted maximum oxygen recording (VO
primary result measurements
The authors examined 2 primary endpoints: the development of CRC and the maximum polyp diameter, measured during colonoscopies that were carried out up to 3 years ago up to 2 years after the step test. The authors compared these two results with the VO of the participants
important knowledge
Even after adjustments to age, gender, surgical history, alcohol consumption and smoking status, the risk of CRC was significantly higher 2 max compared to those with high VO
In the 40 participants without a colectomy in the history, the maximum polyp diameter was similarly significantly negative with the VO maximum ( r = - 0.44, p <0.01).
practice implications
The researchers found that although more and more epidemiological evidence show the positive effect of physical activity on the prevention of sporadic CRC,
Although the mechanism of action of movement in CRC prevention remains unclear, possibly due to the large number of biological signal paths that are influenced by physical activity, a number of potential mechanisms were proposed. Movement can reduce the inflammation of the colon, a crucial factor for the progression of the tumor; A higher degree of physical activity at the beginning of the study is associated with lower concentrations of prostaglandin e As the results of this study show, the effects of regular exercise and adequate physical conditioning can also extend to other forms of CRC in which genetic mutations play a role. This latter-mentioned effect of physical activity on insulin metabolism can provide an indication of the potential effect of physical activity on hereditary non-polyped colorectal carcinoma (HNPCC). Zecevic et al. (2006) found a possible connection between a mutation in the insulin-like growth factor (IGF) and an increased risk of CRC in patients with HNPCC. They showed that variants of the IGF-1 genotype with shorter cytosine adenades (CA) reimbursement promoter lengths were strongly associated with the development of malignancy at HNPCC. In fact, the time until the inserting of CRC decreased with every acceptance of the CA reimbursement number (HR = 1.17; 95 % KI: 1.05–1.31; p = 0.006) and patients with a CA < 17 repetition allelele had a statistically higher risk risk (HR = 2.36; 95 % KI: 1,28–4,36; But one of the main interactions between these related hormones is the stimulating effect of insulin on IGF-1 synthesis. 18 Therefore, movement as a modulator of insulin level as treatment for the treatment of increased IF-1 production in HNPCC can be promising. This theory is promising, since Kim et al. (2005) Research carried out that moderate training reduces the circulating mirror of insulin and IGF-1 over a long period of time.
physical activity to reduce the risk of a sporadic and genetically conditioned CRC is an effective treatment that goes beyond its effectiveness, as has been repeatedly explained - it is free of charge and easily accessible to all patients. In the field of medicine, especially in the area of oncology, the seduction of innovation and technology can often lead to simple but effective strategies for both doctors and patients. Nakamura et al. remind us of the crucial importance of primary prevention and illustrate how nature, here a genetic predisposition for CRC, can be influenced by suitable care.
- Boyle T, Keegel T, Bull F, Heyworth J, Fritschi L. Physical activity and risks of proximal and distal colon cancer: a systematic review and meta -analysis. J National Cancer Inst . 2012; 104 (20): 1548-156
- t. Ioka, H. Ishikawa, I. Akedo et al. Correction of the study on the prevention of colon cancer by changing the lifestyle: an introduction to the protocol: illustration [ Asian pac j Cancer PREV . 2001; 2 (3): 233-236]. Asian-Pacific J-cancer beforehand . 2001; 2 (4): 319.
- Martínez me. Primary prevention of colon cancer: lifestyle, nutrition, movement. recent results Cancer res . 2005; 166: 177-211.
- Winawer SJ, Fletcher Rh, Miller L, et al. Colon cancer screening: clinical guidelines and justification. gastroenterology . 1997; 112 (2): 594-642.
- Burn J, Bishop DT, Chapman PD, et al. A randomized placebo -controlled prevention study with aspirin and/or resistant strength in young people with family adenomatous polyposis. cancer . 2011; 4 (5): 655-66
- Steinbach G, Lynch PM, Phillips RKS, et al. The effect of Celecoxib, a cyclooxygenase-2 inhibitor, with family adenomatous polyposis. n Engl. J med . 2000; 342 (26): 1946-1952.
- Phillips RKS, Wallace MH, Lynch PM, et al. A randomized, double-blind, placebo-controlled study with Celecoxib, a selective cyclooxygenase-2 inhibitor, in polyposis duodeni, family adenomatous polyposis. intestine . 2002; 50 (6): 857-860.
- lynch PM, Ayers GD, Hawk e, et al. The safety and effectiveness of Celecoxib in children with family adenomatous polyposis. Am J Gastroenterol . 2010; 105 (6): 1437-1443.
- Samadder NJ, Neklason DW, Boucher KM, et al. Effect of Sulindac and Erlotinib vs. Placebo on duodenalneoplasia in family adenomatous polyposis: a randomized clinical study. Jama . 2016; 315 (12): 1266-1275.
- Samadder NJ, Kuwada SK, Boucher KM, et al. Association of Sulindac and Erlotinib vs. Placebo with colorectal neoplasia in family adenomatous polyposis: secondary analysis of a randomized clinical study. Jama oncol . 2018; 4 (5): 671-677.
- Cruz-Correa M, Shoskes da, Sanchez P, et al. Combination treatment with curcumin and quercetin of adenomes in family adenomatous polyposis. Clin Gastroenterol Hepatol . 2006; 4 (8): 1035-1038.
- Martínez Me, Heddens D, Earnest DL, et al. Physical activity, body mass index and prostaglandin-E2 mirror in the rectal mucous membrane. J National Cancer Inst . 1999; 91 (11): 950-953.
- Goodyear LJ, Kahn BB. Movement, glucose transport and insulin sensitivity. year Rev. Med . 1998; 49: 235-61.
- Giovannucci E. Insulin and colon cancer. cancer causes control . 1995; 6 (2): 164-179.
- Schoen Re, Tangen cm, Kuller LH, et al. Increased blood sugar and insulin, height and occurrence of colon cancer. J National Cancer Inst . 1999; 91 (13): 1147-1154.
- Zecevic M, Amos CI, GU X, et al. IGF1 gene polymorphism and risk of hereditary colon cancer without polyposis. J National Cancer Inst . 2006; 98 (2): 139-143.
- rosen CJ, Kurland es, Vereult d, et al. Association between serum insulin growth factor-i (IGF-I) and a simple sequence decomposition in the IGF-I gene: implications for genetic studies of bone mineral density. j clin endocrinol metab . 1998; 83 (7): 2286-2290.
- Laron Z. IGF-1 and insulin as growth hormones. In: Bock G., Good J., ed. Novartis found Sympst . Wiley online library; 2004; 262: 56-77; Discussion 77-83, 265-8.
- Kim t, Chang Js, Kim H, Kong Id. Serum-IGF-1 and -IGFBP3 influence intensive work. J lifestyle med . 2015; 5 (1): 21-25.
- Courneya KS, Friedenreich cm, Quinney ha, Fields ala, Jones LW, Fairey as. A randomized study on the movement and quality of life in survivors of colon cancer. EUR J Cancer Care . 2003; 12 (4): 347-357.